aspartic acid has been researched along with docetaxel anhydrous in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annable, T; Greenberger, LM; Hari, M; Loganzo, F; Morilla, DB; Musto, S; Nettles, JH; Snyder, JP; Tan, X | 1 |
| Che, X; He, Z; Kou, L; Li, J; Lian, H; Luo, Q; Sun, J; Tao, W; Yang, B | 1 |
| Babu, PV; Chitkara, D; Khurana, RK; Kumar, V; Raza, K; Sharma, S; Singh, B; Thotakura, N | 1 |
3 other study(ies) available for aspartic acid and docetaxel anhydrous
| Article | Year |
|---|---|
Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents, Phytogenic; Aspartic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Epothilones; Glutamic Acid; Humans; Mice; Mice, Nude; Microtubules; Paclitaxel; Point Mutation; Protein Conformation; Taxoids; Tubulin; Verapamil | 2006 |
ATB
Topics: Amino Acid Transport Systems; Amino Acid Transport Systems, Neutral; Antineoplastic Agents; Aspartic Acid; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Liposomes; Lung Neoplasms; Microscopy, Confocal; Molecular Structure; Taxoids | 2017 |
Aspartic acid tagged carbon nanotubols as a tool to deliver docetaxel to breast cancer cells: Reduced hemotoxicity with improved cytotoxicity.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers; Drug Liberation; Drug Synergism; Humans; Nanotubes, Carbon; Rats, Wistar | 2019 |